Helius Medical Technologies, Inc.
HSDT
$0.39
-$0.01-2.50%
| Weiss Ratings | HSDT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | HSDT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | HSDT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.89 | |||
| Price History | HSDT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -2.52% | |||
| 30-Day Total Return | -27.51% | |||
| 60-Day Total Return | -46.57% | |||
| 90-Day Total Return | -9.34% | |||
| Year to Date Total Return | -44.48% | |||
| 1-Year Total Return | -93.66% | |||
| 2-Year Total Return | -96.86% | |||
| 3-Year Total Return | -99.77% | |||
| 5-Year Total Return | -99.92% | |||
| 52-Week High % Change | -94.11% | |||
| 52-Week Low % Change | 7.24% | |||
| Price | HSDT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $6.79 | |||
| 52-Week Low Price | $0.37 | |||
| 52-Week Low Price (Date) | Oct 15, 2024 | |||
| 52-Week High Price (Date) | Apr 08, 2024 | |||
| Valuation | HSDT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 2.45M | |||
| Enterprise Value | 1.37M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -5.76 | |||
| Earnings Per Share Growth | -59.75% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 2.88 | |||
| Price/Book (Q) | 1.41 | |||
| Enterprise Value/Revenue (TTM) | 2.64 | |||
| Price | $0.39 | |||
| Enterprise Value/EBITDA (TTM) | -0.10 | |||
| Enterprise Value/EBIT | -0.10 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | HSDT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 3.75M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | HSDT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 215 944 6100 | |||
| Address | 642 Newtown Yardley Road Newtown, PA 18940 | |||
| Website | heliusmedical.com | |||
| Country | United States | |||
| Year Founded | 2014 | |||
| Profitability | HSDT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -2,665.96% | |||
| Profit Margin | -2,258.07% | |||
| Management Effectiveness | HSDT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -154.25% | |||
| Return on Equity | -- | |||
| Income Statement | HSDT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 476.00K | |||
| Total Revenue (TTM) | 520.00K | |||
| Revenue Per Share | $0.14 | |||
| Gross Profit (TTM) | -62.00K | |||
| EBITDA (TTM) | -13.80M | |||
| EBIT (TTM) | -13.86M | |||
| Net Income (TTM) | -11.74M | |||
| Net Income Avl. to Common (TTM) | -11.74M | |||
| Total Revenue Growth (Q YOY) | 13.43% | |||
| Earnings Growth (Q YOY) | -275.89% | |||
| EPS Diluted (TTM) | -5.76 | |||
| EPS Diluted Growth (Q YOY) | 28.95% | |||
| Balance Sheet | HSDT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 1.09M | |||
| Cash Per Share (Q) | $0.29 | |||
| Total Current Assets (Q) | 3.42M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 1.06M | |||
| Current Ratio (Q) | 1.583 | |||
| Book Value Per Share (Q) | $0.28 | |||
| Total Assets (Q) | 3.54M | |||
| Total Current Liabilities (Q) | 2.16M | |||
| Total Debt (Q) | 12.00K | |||
| Total Liabilities (Q) | 2.48M | |||
| Total Common Equity (Q) | 1.06M | |||
| Cash Flow | HSDT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -5.00K | |||
| Cash from Financing (TTM) | 6.95M | |||
| Net Change in Cash (TTM) | -4.09M | |||
| Levered Free Cash Flow (TTM) | -5.86M | |||
| Cash from Operations (TTM) | -11.04M | |||
